NLRP3 and breast carcinoma: Jin et al. reported that the NLRP3 inflammasome can be induced and activated by P2Y purinergic receptor 2 (P2Y2R) in metastatic breast cancer cells, enhancing tumor invasion and tumor growth, and contributing to tumor progression [61].